Ken Liao
About
Ken Liao has authored 22 papers that have received a total of 414 indexed citations.
This includes 7 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Cancer Research. The topics of these papers are Biosimilars and Bioanalytical Methods (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Effects and risks of endocrine disrupting chemicals (4 papers). Ken Liao is often cited by papers focused on Biosimilars and Bioanalytical Methods (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Effects and risks of endocrine disrupting chemicals (4 papers) and collaborates with scholars based in United States, China and Singapore. Ken Liao's co-authors include Yu‐Mei Tan, Harvey J. Clewell, Donghua Yin, Melvin E. Andersen and Jason H. Williams and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Pharmacology & Therapeutics and Frontiers in Plant Science
In The Last Decade
Explore authors with similar magnitude of impact
Top authors papers by E Bouvet are co-authored with Top fields papers by Linghan Gao are about Top countries impacted by papers by Rodolfo Rendón‐Villalobos Top countries impacted by papers by M. Vuillaume Top countries impacted by papers by Karen Schipper Top authors papers by Ulrich K. Kesselring are co-authored with Top journals papers by Ahmet Karagüzel are published in Top authors papers by Helena Fortunato are co-authored with